Search

everythinglearnresearchcommunity

for

Search:↓

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Stopping the depression medication improved the woman's eyebrow hair loss, and a treatment for a skin condition caused by mites was effective.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Fever and rash can be early signs of lupus.

Following treatment plans is crucial to prevent worsening skin and hair conditions.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

A man had both alopecia areata and lichen planus, which is uncommon.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Early identification of lupus through skin signs and blood tests is crucial in India.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.